Although expression levels of GSDME and GSDMB were positively correlated with clinical benefit in several kinds of cancers, increased GSDMB expression was associated with poor clinical outcome in breast cancer [28,30,64,74,75]. Here, GSDMB is linked to breast carcinoma.